Provider 1710064878
NPI: 1710064878Share
Active Billing Period:2018-01→2024-11(83 months)
Extreme procedure concentration — 100% of $12.2M billed through just 2 codes
Total Paid
$12.2M
$12,182,835
Total Claims
2,805
Beneficiaries
2,526
1.1 claims/patient
Avg Cost/Claim
$4K
Monthly Spending Trend
Yearly Spending
2018
$2.7M
-29%
2019
$1.9M
-3%
2020
$1.9M
+0%
2021
$1.9M
-25%
2022
$1.4M
-13%
2023
$1.2M
-8%
2024
$1.1M
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 2 distinct procedure codes. The top code (Q5003 (Injection, infliximab-dyyb, biosimilar, 10 mg)) accounts for 100% of total spending.
ProcedureTotalYour Cost/ClaimNational Medianvs MedianPercentile